Stryker Corp
SYK373.198USD
-0.722-0.19%
Market hours （ET）Quotes delayed by 15 min
142.34BMarket Cap
47.56P/E TTM
More Details of Stryker Corp Company
Stryker Corporation is a medical technology company. The Company offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The Company also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.
Company Info
Company codeSYK
Company nameStryker Corp
IPO dateMar 17, 1980
Founded at1946
CEOMr. Kevin A. Lobo
Number of employees53000
Security typeOrdinary Share
Fiscal year-endMar 17
Address1941 Stryker Way
CityPORTAGE
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code49002
Phone12693852600
Websitehttps://www.stryker.com/
Company codeSYK
IPO dateMar 17, 1980
Founded at1946
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Kevin A. Lobo
Mr. Kevin A. Lobo
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
122.99K
+22.11%
Mr. Spencer S. Stiles
Mr. Spencer S. Stiles
Group President - Orthopaedics and Spine
Group President - Orthopaedics and Spine
64.47K
+13.09%
Ms. Ronda E. Stryker
Ms. Ronda E. Stryker
Independent Director
Independent Director
45.34K
-52.57%
Ms. Yin C. Becker
Ms. Yin C. Becker
Vice President - Chief Corporate Affairs Officer
Vice President - Chief Corporate Affairs Officer
33.06K
+2.71%
Mr. Allan C. Golston, CPA
Mr. Allan C. Golston, CPA
Independent Director
Independent Director
14.24K
+14.74%
Mr. Viju S. Menon
Mr. Viju S. Menon
Group President - Global Quality and Operations
Group President - Global Quality and Operations
13.19K
+42.64%
Mr. Robert S. Fletcher
Mr. Robert S. Fletcher
Vice President, Chief Legal Officer
Vice President, Chief Legal Officer
10.38K
+50.92%
Mr. Preston W. Wells
Mr. Preston W. Wells
Chief Financial Officer, Vice President
Chief Financial Officer, Vice President
7.25K
--
Ms. Mary K. Brainerd
Ms. Mary K. Brainerd
Independent Director
Independent Director
5.82K
+0.90%
Mr. Rajeev Suri
Mr. Rajeev Suri
Independent Director
Independent Director
5.21K
+1.01%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Kevin A. Lobo
Mr. Kevin A. Lobo
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
122.99K
+22.11%
Mr. Spencer S. Stiles
Mr. Spencer S. Stiles
Group President - Orthopaedics and Spine
Group President - Orthopaedics and Spine
64.47K
+13.09%
Ms. Ronda E. Stryker
Ms. Ronda E. Stryker
Independent Director
Independent Director
45.34K
-52.57%
Ms. Yin C. Becker
Ms. Yin C. Becker
Vice President - Chief Corporate Affairs Officer
Vice President - Chief Corporate Affairs Officer
33.06K
+2.71%
Mr. Allan C. Golston, CPA
Mr. Allan C. Golston, CPA
Independent Director
Independent Director
14.24K
+14.74%
Mr. Viju S. Menon
Mr. Viju S. Menon
Group President - Global Quality and Operations
Group President - Global Quality and Operations
13.19K
+42.64%
Revenue Breakdown
Currency: USDUpdate time: Sun, Apr 6
Currency: USDUpdate time: Sun, Apr 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Medical
3.85B
17.05%
Trauma and Extremities
3.51B
15.52%
Endoscopy
3.39B
15.00%
Instruments
2.83B
12.54%
Knees
2.45B
10.83%
Other
6.57B
29.06%
By RegionUSD
Name
Revenue
Proportion
United States
16.94B
74.99%
Europe & Middle East & Africa (EMEA) (Region)
2.90B
12.82%
Asia Pacific (Region)
2.02B
8.94%
Other countries
735.00M
3.25%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Medical
3.85B
17.05%
Trauma and Extremities
3.51B
15.52%
Endoscopy
3.39B
15.00%
Instruments
2.83B
12.54%
Knees
2.45B
10.83%
Other
6.57B
29.06%
Shareholder
Update time: Fri, Feb 21
Update time: Fri, Feb 21
Shareholder Statistics
Type
Shareholder Statistics
Shareholder
Proportion
The Vanguard Group, Inc.
8.53%
Brown (John W)
5.25%
Greenleaf Trust
4.48%
BlackRock Institutional Trust Company, N.A.
4.34%
State Street Global Advisors (US)
3.87%
Other
73.52%
Shareholder Statistics
Shareholder
Proportion
The Vanguard Group, Inc.
8.53%
Brown (John W)
5.25%
Greenleaf Trust
4.48%
BlackRock Institutional Trust Company, N.A.
4.34%
State Street Global Advisors (US)
3.87%
Other
73.52%
Type
Shareholder
Proportion
Investment Advisor
35.96%
Investment Advisor/Hedge Fund
29.85%
Bank and Trust
6.62%
Individual Investor
5.37%
Research Firm
2.92%
Pension Fund
1.98%
Sovereign Wealth Fund
1.34%
Hedge Fund
0.86%
Foundation
0.18%
Other
14.93%
Institutional Shareholding
Update time: Thu, Feb 20
Update time: Thu, Feb 20
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
3383
326.28M
85.48%
-4.42M
2024Q4
3392
326.31M
85.52%
-6.25M
2024Q3
3219
327.28M
85.85%
-2.63M
2024Q2
3172
322.05M
84.52%
-4.86M
2024Q1
3130
320.11M
84.03%
-8.55M
2023Q4
3047
327.61M
86.24%
+19.84M
2023Q3
2938
324.92M
85.54%
+14.80M
2023Q2
2898
325.04M
85.60%
+10.05M
2023Q1
2838
330.33M
87.03%
+17.40M
2022Q4
2800
311.07M
82.21%
-3.07M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
32.55M
8.53%
+257.04K
+0.80%
Dec 31, 2024
Brown (John W)
20.06M
5.25%
--
--
Feb 28, 2025
Greenleaf Trust
17.39M
4.56%
-355.66K
-2.00%
Feb 28, 2025
BlackRock Institutional Trust Company, N.A.
16.58M
4.34%
-688.56K
-3.99%
Dec 31, 2024
State Street Global Advisors (US)
14.78M
3.87%
+196.16K
+1.35%
Dec 31, 2024
T. Rowe Price Associates, Inc.
10.61M
2.78%
+48.98K
+0.46%
Dec 31, 2024
Wellington Management Company, LLP
8.38M
2.19%
-1.72M
-17.01%
Dec 31, 2024
Fidelity Management & Research Company LLC
7.37M
1.93%
+749.68K
+11.32%
Dec 31, 2024
Geode Capital Management, L.L.C.
7.07M
1.85%
+168.44K
+2.44%
Dec 31, 2024
Capital Research Global Investors
6.84M
1.79%
-210.56K
-2.99%
Dec 31, 2024
View more
Related ETFs
Update time: Sun, Apr 6
Update time: Sun, Apr 6
Name
Proportion
Jensen Quality Growth ETF
6.4%
Parnassus Core Select ETF
4.69%
iShares U.S. Medical Devices ETF
4.18%
AdvisorShares Focused Equity ETF
4.05%
Gabelli Growth Innovators ETF
3.41%
Democratic Large Cap Core ETF
3.32%
JPMorgan Healthcare Leaders ETF
3.22%
Indexperts Quality Earnings Focused ETF
3.11%
Global X Aging Population ETF
2.92%
Tema Neuroscience and Mental Health ETF
2.76%
View more
Jensen Quality Growth ETF
Proportion6.4%
Parnassus Core Select ETF
Proportion4.69%
iShares U.S. Medical Devices ETF
Proportion4.18%
AdvisorShares Focused Equity ETF
Proportion4.05%
Gabelli Growth Innovators ETF
Proportion3.41%
Democratic Large Cap Core ETF
Proportion3.32%
JPMorgan Healthcare Leaders ETF
Proportion3.22%
Indexperts Quality Earnings Focused ETF
Proportion3.11%
Global X Aging Population ETF
Proportion2.92%
Tema Neuroscience and Mental Health ETF
Proportion2.76%
Dividend
A total of
5.22B
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Dec 10, 2024
SYK.NB Final Cash Dividend of gross USD 0.84 paid on Jan 31, 2025 going ex on Dec 31, 2024
Dec 31, 2024
Jan 31, 2025
Dec 31, 2024
Aug 07, 2024
SYK.NB Interim Cash Dividend of gross USD 0.8 paid on Oct 31, 2024 going ex on Sep 30, 2024
Sep 30, 2024
Oct 31, 2024
Sep 30, 2024
May 09, 2024
SYK.NB Interim Cash Dividend of gross USD 0.8 paid on Jul 31, 2024 going ex on Jun 28, 2024
Jun 28, 2024
Jul 31, 2024
Jun 28, 2024
Feb 07, 2024
SYK.NB Interim Cash Dividend of gross USD 0.8 paid on Apr 30, 2024 going ex on Mar 27, 2024
Mar 29, 2024
Apr 30, 2024
Mar 27, 2024
Dec 05, 2023
SYK.NB Final Cash Dividend of gross USD 0.8 paid on Jan 31, 2024 going ex on Dec 28, 2023
Dec 29, 2023
Jan 31, 2024
Dec 28, 2023
Aug 02, 2023
SYK.NB Interim Cash Dividend of gross USD 0.75 paid on Oct 31, 2023 going ex on Sep 28, 2023
Sep 29, 2023
Oct 31, 2023
Sep 28, 2023
May 10, 2023
SYK.NB Interim Cash Dividend of gross USD 0.75 paid on Jul 31, 2023 going ex on Jun 29, 2023
Jun 30, 2023
Jul 31, 2023
Jun 29, 2023
Feb 09, 2023
SYK.NB Interim Cash Dividend of gross USD 0.75 paid on Apr 28, 2023 going ex on Mar 30, 2023
Mar 31, 2023
Apr 28, 2023
Mar 30, 2023
Dec 07, 2022
SYK.NB Final Cash Dividend of gross USD 0.75 paid on Jan 31, 2023 going ex on Dec 29, 2022
Dec 30, 2022
Jan 31, 2023
Dec 29, 2022
Aug 03, 2022
SYK.NB Interim Cash Dividend of gross USD 0.695 paid on Oct 31, 2022 going ex on Sep 29, 2022
Sep 30, 2022
Oct 31, 2022
Sep 29, 2022
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data